hematopoietic stem cell therapy (Gamida/Weill)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehematopoietic stem cell therapy (Gamida/Weill)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionStem cells modulators
TargetsUpdating
Therapy Area/Indicationsbeta-Thalassemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGamida Cell Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWeill Medical College of Cornell UniversityGamida Cell Ltd
Active IndicationsN/A
Inactive Indicationsbeta-Thalassemia

Other Information

ATC CodeN/A
Related LinksN/A